The overall objective of the Brain Cancer Program is to translate insights into glial cell biology and cancer genetics into improved treatments for brain tumor patients. Advances in diagnostic imaging, neurological surgery, and radiation therapy have improved brain tumor treatment by making possible earlier detection, safer surgical removal, and more accurate radiation targeting. Nevertheless, treatment of malignant gliomas remains unsatisfactory on account of their diffuse infiltration throughout the brain and their inconsistent response to radiation and chemotherapy. The clinical research program is based on the premise that early identification of brain tumors using state-of-the-art imaging, coupled with precision stereotactic biopsy and resection a and consistent neuropathologic diagnosis and staging, is the best method for establishing a rational basis for treatment. A central aim of the overall research program is to develop an improved classification scheme of human gliomas based on the glial cell lineage and molecular genetics of individual tumors, that allows better prediction of differences in treatment responsiveness of gliomas that appear histopathologically identical but may be of different lineage origin and/or many have different genetic abnormalities. Basic research programs also include efforts to elucidate the biology of the precursor cells that give rise to normal and neoplastic CNS tissue, analysis of the interactions between glial cells and neurons, investigator of neurotransmitter receptor structure and function, analysis of the biology if inflammation in the CNS, development of improved therapeutic procedures, enhancement of imaging capacity and interpretation of the information obtained through non-invasive imaging techniques, and mechanistic analysis of the basis for neurological disease. In addition, the creation of the Center for Advanced Technologies (CAMT) has significantly enhanced our local imaging capabilities. Future aims are to initiate clinical investigation of the utility of differentiation markers in treatment stratification of patients with malignant astrocytoma; investigate the efficacy of functional imaging, particularly magnetic source imaging, in maximizing the benefit of surgical resection; implement clinical trials of noel therapeutic approaches; develop and implement methods to improve delivery of macromolecules to tumors; establish the utility of radiation beam-sharing as an improved adjunct therapy; establish new preclinical models for tumors of the CNS that more closely resemble human gliomas in their biology than do present animal models; expand and integrate into clinical application the studies of basic cellular and molecular mechanisms in neurological dysfunction (e.g. receptors and ion channels).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-15
Application #
6591245
Study Section
Project Start
2002-05-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
15
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Park, Jihye; Blackburn, Brenna E; Rowe, Kerry et al. (2018) Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study. Ann Epidemiol 28:377-384
Hardy, Christopher M; Burke, Molly K; Everett, Logan J et al. (2018) Genome-Wide Analysis of Starvation-Selected Drosophila melanogaster-A Genetic Model of Obesity. Mol Biol Evol 35:50-65
Gilcrease, Eddie B; Casjens, Sherwood R (2018) The genome sequence of Escherichia coli tailed phage D6 and the diversity of Enterobacteriales circular plasmid prophages. Virology 515:203-214
Curtin, Karen; Fleckenstein, Annette E; Keeshin, Brooks R et al. (2018) Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder. Neuropsychopharmacology 43:2548-2555
Fowler, Brynn; Ding, Qian; Pappas, Lisa et al. (2018) Utah Cancer Survivors: A Comprehensive Comparison of Health-Related Outcomes Between Survivors and Individuals Without a History of Cancer. J Cancer Educ 33:214-221
Wu, Yelena P; Kohlmann, Wendy; Curtin, Karen et al. (2018) Melanoma risk assessment based on relatives' age at diagnosis. Cancer Causes Control 29:193-199
Burch, Joseph S; Marcero, Jason R; Maschek, John Alan et al. (2018) Glutamine via ?-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis. Blood 132:987-998
Fowler, Brynn; Samadder, N Jewel; Kepka, Deanna et al. (2018) Improvements in Colorectal Cancer Incidence Not Experienced by Nonmetropolitan Women: A Population-Based Study From Utah. J Rural Health 34:155-161
Grieshober, Laurie; Graw, Stefan; Barnett, Matt J et al. (2018) Methylation-derived Neutrophil-to-Lymphocyte Ratio and Lung Cancer Risk in Heavy Smokers. Cancer Prev Res (Phila) 11:727-734
Philip, Beatrice; Yu, Diana X; Silvis, Mark R et al. (2018) Mutant IDH1 Promotes Glioma Formation In Vivo. Cell Rep 23:1553-1564

Showing the most recent 10 out of 1193 publications